|
Real-time Estimate
Cboe BZX
15:43:27 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 83.66 USD | +5.14% |
|
+3.49% | +26.26% |
| 10-05 | Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing | MT |
| 09-20 | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to S&P Biotechnology Select Industry Index | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MNPR | Delayed | |
CBOE
| MNPR | Real-time | |
Tradegate
| 1IY0 | Real-time | |
Deutsche Boerse AG
| 1IY0 | Delayed | |
Boerse Muenchen
| 1IY0 | Real-time | |
Börse Stuttgart
| 1IY0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 96.63 | 123.84 | 119.21 |
| Spread/Res. | -14.67% | -33.42% | -30.84% |
| Spread/Supp. | +5.75% | +64.51% | +54.98% |
| Support | 77.97 | 50.12 | 53.2 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MNPR Stock
- Charts Monopar Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions

















